← Back to catalogue

Tigsun VVC/TV/GV Combo Antigen Test

EUDAMED

Class IVD General (EU MDR)

Ref N/AModel 1 testModel 5 testsModel 10 testsModel 40 testsModel 25 tests

by Beijing Tigsun Diagnostics Co., Ltd.

Identity

Device Name
Tigsun VVC/TV/GV Combo Antigen Test EUDAMED
Model / Reference
1 test EUDAMED
N/A EUDAMED
5 tests EUDAMED
10 tests EUDAMED
40 tests EUDAMED
25 tests EUDAMED

Identifiers

Primary DI / UDI-DI
06973642381032 EUDAMED
06973642381049 EUDAMED
06973642381056 EUDAMED
06973642381087 EUDAMED
06973642381070 EUDAMED
Basic UDI-DI
B-06973642381032 EUDAMED
B-06973642381049 EUDAMED
B-06973642381056 EUDAMED
B-06973642381087 EUDAMED
B-06973642381070 EUDAMED
EMDN Code
W0105040699 VIRAL ANTIGEN/ANTIBODY DETECTION - OTHER EUDAMED

Classification

Device Class
Class IVD General EUDAMED
Market of Registration
Austria EUDAMED

Clinical & Handling

Sterile

No

EUDAMED

Human Tissues

No

EUDAMED

Animal Tissues

No

EUDAMED

Microbial Substances

No

EUDAMED

Reagent

Yes

EUDAMED

Self Testing

No

EUDAMED

Near-Patient Testing

Yes

EUDAMED

Professional Testing

Yes

EUDAMED

Companion Diagnostics

No

EUDAMED

Surgical Instrument

No

EUDAMED

Tigsun VVC/TV/GV Combo Antigen Test by Beijing Tigsun Diagnostics Co., Ltd. — Class IVD General — IVDD — listed in EUDAMED — regulatory data on deviCERTS

Authorization Coverage (European Union — 27 member states)

Regulatory Authorizations

European Union Active

CE/IVDD

Is this your device? Claim it to add documentation and request validation.

Manufacturer

EUDAMED SRN
CN-MF-000034480
Authorised Representative
CMC Medical Devices & Drugs SL ES-AR-000000293

Sources (5)

  • EUDAMED 5ad1a98f-9da1-4d8a-a1a9-a5517d1e02bd 61 fields · synced Sep 17, 2026
  • EUDAMED cbfa3718-24e3-4fa1-8c8f-333591274dc2 61 fields · synced May 17, 2026
  • EUDAMED e461db93-8cbd-4967-90db-43573543edb8 61 fields · synced May 18, 2026
  • EUDAMED 066d8ae1-ee74-4453-a024-03eb9c17ffe0 61 fields · synced May 18, 2026
  • EUDAMED 1d99dd5b-8073-45b3-a770-f12b7f18d01a 61 fields · synced May 18, 2026